(ANSA) – BEIJING, 11 SEPTEMBER – Hong Kong will soon begin clinical trials for the first vaccine in the form of a nasal spray against Covid-19: Hong Kong University announced it after the green light of the Chinese authorities. developed the substance together with Xiamen University and Beijing Wantai University of Pharmaceutical Biology.
Microbiologist Yuen Kwok-yung explained to the Hong Kong media that clinical trials should begin in November and that the university has already received funding for 2.1 million euros, while the search for 100 healthy people to recruit for the tests. The clinical trial of the spray will consist of three phases and, from the launch of the first, it will take at least a year before the vaccine can be used.
The substance is the first vaccine in the form of a nasal spray to have obtained clinical trial approval from the Chinese National Medical Products Administration to date. (HANDLE).
REPRODUCTION RESERVED © Copyright ANSA